ZURICH (Reuters) - Actelion Ltd, Europe's largest biotech company, said on Thursday the U.S. Food and Drug Administration (FDA) would review use of its drug Zavesca to treat a rare neurodegenerative disease early next year. Full Story »
WASHINGTON (Reuters) - Villagers in the highlands of Papua New Guinea who ritualistically ate human brains but did not die of a brain disease called kuru have a genetic mutation that protects them, researchers said Wednesday. Full Story »
TUESDAY, Nov. 17 (HealthDay News) -- Oil from genetically modified soybeans boosts levels of an important omega-3 fatty acid in the body, which may reduce the risk of heart attacks, U.S. researchers say. Full Story »
TUESDAY, Nov. 17 (HealthDay News) -- Patients who received bone marrow stem cell transplants during coronary bypass surgery (CABG) experienced "excellent long-term safety and survival," say German researchers, who also noted the first promising results for stem cell transplantation during mitral valve repair. Full Story »
WASHINGTON (Reuters) - Iceland's Decode Genetics Inc, a pioneer in genetic research, has filed for bankruptcy protection, weighed down by debts after 13 years of failing to make a profit. Full Story »
Archon X Prize for Genomics
LOS ANGELES (AFP) - A Taiwanese group has entered the running for the 10-million-dollar Archon X Prize for Genomics competition, the biggest medical prize in history, organizers said Tuesday. Full Story »
WASHINGTON — A whirlwind of activity is under way to apply the findings of the $3 billion Human Genome Project to improve health care in the United States and around the world. Full Story »
NEW YORK (Reuters) - Lobbyists working for biotech company Genentech wrote statements for more than a dozen lawmakers in the official record of the House debate on the health care bill, The New York Times reported on Sunday, citing e-mails. Full Story »
HONG KONG (Reuters) - People of Japanese and European descent who have mutant versions of five genes may be at higher risk of developing Parkinson's disease, two large teams of researchers have found. Full Story »
AP
WASHINGTON - Federal health regulators have found tiny particles of trash in drugs made by Genzyme, the second time this year the biotechnology company has been cited for contamination issues. Full Story »
Reuters
ENID, Oklahoma (Reuters) - To the untrained eye, Pollard Farms looks much like any other cattle ranch. Similar looking cows are huddled in similar looking pens. But some of the cattle here don't just resemble each other. They are literally identical -- clear down to their genes. Full Story »
THURSDAY, Nov. 12 (HealthDay News) -- Researchers are reporting that injections of genes into the leg muscles of monkeys helped the animals gain muscle size and strength without side effects. Full Story »
WASHINGTON (Reuters) - A gene therapy treatment that stops the breakdown of muscle appeared safe in monkeys and may build up muscle, too, researchers reported on Wednesday. Full Story »
Reuters
WASHINGTON (Reuters) - Why can humans talk and chimps cannot? Researchers said on Wednesday they have another clue and it lies not simply in the genetic code, but in how the genes function. Full Story »
LONDON (Reuters) - A mouse that can speak? A monkey with Down's Syndrome? Dogs with human hands or feet? British scientists want to know if such experiments are acceptable, or if they go too far in the name of medical research. Full Story »
Add headlines to your personalized My Yahoo! page (About My Yahoo! and RSS)
Science Photos
